{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,4]],"date-time":"2026-11-04T00:03:33Z","timestamp":1793750613175,"version":"4.6.1"},"reference-count":52,"publisher":"Springer Science and Business Media LLC","issue":"1","funder":[{"DOI":"10.13039\/501100007437","name":"TrygFonden","doi-asserted-by":"publisher","award":["109436"],"award-info":[{"award-number":["109436"]}],"id":[{"id":"10.13039\/501100007437","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100005275","name":"Region Hovedstaden","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100005275","id-type":"DOI","asserted-by":"publisher"}]},{"name":"The Medication Fund of the Regions of Denmark","award":["15\/1716"],"award-info":[{"award-number":["15\/1716"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Trials"],"published-print":{"date-parts":[[2017,12]]},"DOI":"10.1186\/s13063-017-2172-4","type":"journal-article","created":{"date-parts":[[2017,9,29]],"date-time":"2017-09-29T18:16:42Z","timestamp":1506709002000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":28,"title":["TAILOR \u2013 tapered discontinuation versus maintenance therapy of antipsychotic medication in patients with newly diagnosed schizophrenia or persistent delusional disorder in remission of psychotic symptoms: study protocol for a randomized clinical trial"],"prefix":"10.1186","volume":"18","author":[{"given":"Anne Emilie","family":"St\u00fcrup","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Heidi Dorthe","family":"Jensen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Signe","family":"Dolmer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Merete","family":"Birk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nikolai","family":"Albert","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mai","family":"Nielsen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6943-4785","authenticated-orcid":false,"given":"Carsten","family":"Hjorth\u00f8j","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lene","family":"Eplov","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bj\u00f8rn H.","family":"Ebdrup","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ole","family":"Mors","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Merete","family":"Nordentoft","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2017,9,29]]},"reference":[{"key":"2172_CR1","unstructured":"Insel TR. Rethinking schizophrenia. Nature. Nature Publishing Group; 2010;468:187\u201393."},{"key":"2172_CR2","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1016\/j.schres.2013.07.031","volume":"150","author":"SF Austin","year":"2013","unstructured":"Austin SF, Mors O, Secher RG, Hjorth\u00f8j C, Albert N, Bertelsen M, et al. Predictors of recovery in first episode psychosis: The OPUS cohort at 10\u00a0year follow-up. Schizophr Res. 2013;150:163\u20138.","journal-title":"Schizophr Res"},{"key":"2172_CR3","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1037\/a0014708","volume":"23","author":"RI Mesholam-Gately","year":"2009","unstructured":"Mesholam-Gately RI, Giuliano AJ, Goff KP, Faraone SV, Seidman LJ. Neurocognition in first-episode schizophrenia: a meta-analytic review. Neuropsychology. 2009;23:315\u201336.","journal-title":"Neuropsychology"},{"key":"2172_CR4","volume-title":"Psychosis and schizophrenia in adults: prevention and management\u2014Clinical Guideline","author":"National Institute for Health and Care Excellence (NICE)","year":"2014","unstructured":"National Institute for Health and Care Excellence (NICE). Psychosis and schizophrenia in adults: prevention and management\u2014Clinical Guideline. 2014."},{"key":"2172_CR5","doi-asserted-by":"crossref","first-page":"892","DOI":"10.1093\/schbul\/sbu170","volume":"41","author":"P Fusar-Poli","year":"2015","unstructured":"Fusar-Poli P, Papanastasiou E, Stahl D, Rocchetti M, Carpenter W, Shergill S, et al. Treatments of negative symptoms in schizophrenia: meta-analysis of 168 randomized placebo-controlled trials. Schizophr Bull. 2015;41:892\u20139.","journal-title":"Schizophr Bull"},{"key":"2172_CR6","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1093\/oxfordjournals.schbul.a033374","volume":"25","author":"RSE Keefe","year":"1999","unstructured":"Keefe RSE, Silva SG, Perkins DO, Lieberman JA. The effects of atypical antipsychotic drugs on neurocognitive impairment in schizophrenia: a review and meta-analysis. Schizophr Bull. 1999;25:201\u201322.","journal-title":"Schizophr Bull"},{"issue":"10","key":"2172_CR7","doi-asserted-by":"crossref","first-page":"1013","DOI":"10.1016\/j.biopsych.2004.01.027","volume":"55","author":"AL Mishara","year":"2004","unstructured":"Mishara AL, Goldberg TE. A meta-analysis and critical review of the effects of conventional neuroleptic treatment on cognition in schizophrenia: opening a closed book. Biol Psychiatry. 2004;55(10):1013\u201322.","journal-title":"Biol Psychiatry"},{"key":"2172_CR8","doi-asserted-by":"crossref","first-page":"2063","DOI":"10.1016\/S0140-6736(12)60239-6","volume":"379","author":"S Leucht","year":"2012","unstructured":"Leucht S, Tardy M, Komossa K, Heres S, Kissling W, Salanti G, et al. Antipsychotic drugs versus placebo for relapse prevention in schizophrenia: a systematic review and meta-analysis. Lancet. 2012;379:2063\u201371.","journal-title":"Lancet"},{"key":"2172_CR9","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1176\/appi.ajp.161.1.1","volume":"161","author":"American Psychiatric Association (APA)","year":"2004","unstructured":"American Psychiatric Association (APA). Practice guideline for the treatment of patients with schizophrenia, second edition. Am J Psychiatry. 2004;161:1\u201356.","journal-title":"Am J Psychiatry"},{"key":"2172_CR10","unstructured":"Fink-Jensen A, Rasmussen I, Viuff AG, Larsen JT, Schmidt M, Peacock L, et al. Behandlingsvejledning inklusiv l\u00e6gemiddelrekommandation for medicinsk behandling af psykotiske tilstande hos voksne [Internet]. RADS\u2014Raadet Anvendelse af Dyr Sygehusmedicin. 2014. p. 1\u20136. Available from: http:\/\/docplayer.dk\/23054685-Behandlingsvejledning-inklusiv-laegemiddelrekommandation-for-medicinsk-behandling-af-psykotiske-tilstande-hos-voksne.html . Accessed 25 Sept 2017."},{"issue":"2-3","key":"2172_CR11","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1016\/j.schres.2013.08.001","volume":"152","author":"RB Zipursky","year":"2014","unstructured":"Zipursky RB, Menezes NM, Streiner DL. Risk of symptom recurrence with medication discontinuation in first-episode psychosis: a systematic review. Schizophr Res. 2014;152(2-3):408\u201314.","journal-title":"Schizophr Res"},{"key":"2172_CR12","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1016\/j.schres.2008.07.006","volume":"105","author":"GL Daumit","year":"2008","unstructured":"Daumit GL, Goff DC, Meyer JM, Davis VG, Nasrallah HA, McEvoy JP, et al. Antipsychotic effects on estimated 10-year coronary heart disease risk in the CATIE schizophrenia study. Schizophr Res. 2008;105:175\u201387.","journal-title":"Schizophr Res"},{"key":"2172_CR13","doi-asserted-by":"crossref","first-page":"987","DOI":"10.1017\/S1461145712001241","volume":"16","author":"WW Fleischhacker","year":"2013","unstructured":"Fleischhacker WW, Siu CO, Bod\u00e9n R, Pappadopulos E, Karayal ON, Kahn RS. Metabolic risk factors in first-episode schizophrenia: baseline prevalence and course analysed from the European First-Episode Schizophrenia Trial. Int J Neuropsychopharmacol. 2013;16:987\u201395.","journal-title":"Int J Neuropsychopharmacol"},{"key":"2172_CR14","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/S0140-6736(08)61764-X","volume":"373","author":"S Leucht","year":"2009","unstructured":"Leucht S, Corves C, Arbter D, Engel RR, Li C, Davis JM. Second-generation versus first-generation antipsychotic drugs for schizophrenia: a meta-analysis. Lancet. 2009;373:31\u201341.","journal-title":"Lancet"},{"key":"2172_CR15","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1038\/nrendo.2011.156","volume":"8","author":"M Hert De","year":"2011","unstructured":"De Hert M, Detraux J, van Winkel R, Yu W, Correll CU. Metabolic and cardiovascular adverse effects associated with antipsychotic drugs. Nat Rev Endocrinol. 2011;8:114\u201326.","journal-title":"Nat Rev Endocrinol"},{"key":"2172_CR16","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1016\/S2215-0366(17)30078-0","volume":"4","author":"C Hjorth\u00f8j","year":"2017","unstructured":"Hjorth\u00f8j C, St\u00fcrup AE, McGrath JJ, Nordentoft M. Years of potential life lost and life expectancy in schizophrenia: a systematic review and meta-analysis. Lancet Psychiatry. 2017;4:295\u2013301.","journal-title":"Lancet Psychiatry"},{"issue":"1","key":"2172_CR17","doi-asserted-by":"crossref","first-page":"e55176","DOI":"10.1371\/journal.pone.0055176","volume":"8","author":"M Nordentoft","year":"2013","unstructured":"Nordentoft M, Wahlbeck K, H\u00e4llgren J, Westman J, \u00d6sby U, Alinaghizadeh H, et al. Excess mortality, causes of death and life expectancy in 270,770 patients with recent onset of mental disorders in Denmark, Finland and Sweden. PLoS One. 2013;8(1):e55176.","journal-title":"PLoS One"},{"key":"2172_CR18","unstructured":"Rajkumar AP, Horsdal HT, Wimberley T, Cohen D, Mors O, B\u00f8rglum AD, et al. Endogenous and antipsychotic-related risks for diabetes mellitus in young people with schizophrenia: a Danish population-based cohort study. Am J Psychiatry. American Psychiatric Association Arlington, VA; 2017; appi.ajp.2016.1. Available from: http:\/\/ajp.psychiatryonline.org\/doi\/10.1176\/appi.ajp.2016.16040442 .\u00a0Accessed 25 Sept 2017."},{"issue":"2","key":"2172_CR19","doi-asserted-by":"crossref","first-page":"215","DOI":"10.31887\/DCNS.2007.9.2\/jbobes","volume":"9","author":"J Bobes","year":"2007","unstructured":"Bobes J, Garcia-Portilla MP, Bascaran MT, Saiz PA, Bouso\u00f1o M. Quality of life in schizophrenic patients. Dialogues Clin Neurosci. 2007;9(2):215\u201326.","journal-title":"Dialogues Clin Neurosci"},{"key":"2172_CR20","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1016\/j.schres.2015.07.021","volume":"168","author":"SF Austin","year":"2015","unstructured":"Austin SF, Mors O, Budtz-J\u00f8rgensen E, Secher RG, Hjorth\u00f8j CR, Bertelsen M, et al. Long-term trajectories of positive and negative symptoms in first episode psychosis: a 10\u00a0year follow-up study in the OPUS cohort. Schizophr Res. 2015;168:84\u201391.","journal-title":"Schizophr Res"},{"key":"2172_CR21","doi-asserted-by":"crossref","first-page":"2713","DOI":"10.1017\/S0033291714000282","volume":"44","author":"C Morgan","year":"2014","unstructured":"Morgan C, Lappin J, Heslin M, Donoghue K, Lomas B, Reininghaus U, et al. Reappraising the long-term course and outcome of psychotic disorders: the AESOP-10 study. Psychol Med. 2014;44:2713\u201326.","journal-title":"Psychol Med"},{"issue":"12","key":"2172_CR22","doi-asserted-by":"crossref","first-page":"2118","DOI":"10.1017\/S0033291717000563","volume":"47","author":"D Gotfredsen","year":"2017","unstructured":"Gotfredsen D, Wils RS, Hjorth\u00f8j C, Austin SF, Albert N, Secher RG, et al. Stability and development of psychotic symptoms and the use of antipsychotic medication\u2014long-term follow-up. Psychol Med. 2017;47(12):2118\u201329.","journal-title":"Psychol Med"},{"key":"2172_CR23","doi-asserted-by":"crossref","first-page":"654","DOI":"10.4088\/JCP.v68n0502","volume":"68","author":"L Wunderink","year":"2007","unstructured":"Wunderink L, Nienhuis FJ, Sytema S, Slooff CJ, Knegtering R, Wiersma D. Guided discontinuation versus maintenance treatment in remitted first-episode psychosis: relapse rates and functional outcome. J Clin Psychiatry. 2007;68:654\u201361.","journal-title":"J Clin Psychiatry"},{"key":"2172_CR24","doi-asserted-by":"crossref","first-page":"913","DOI":"10.1001\/jamapsychiatry.2013.19","volume":"70","author":"L Wunderink","year":"2013","unstructured":"Wunderink L, Nieboer RM, Wiersma D, Sytema S, Nienhuis FJ. Recovery in remitted first-episode psychosis at 7\u00a0years of follow-up of an early dose reduction\/discontinuation or maintenance treatment strategy. JAMA Psychiat. 2013;70:913.","journal-title":"JAMA Psychiat"},{"key":"2172_CR25","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1001\/archpsyc.1995.03950150005001","volume":"52","author":"PL Gilbert","year":"1995","unstructured":"Gilbert PL, Harris MJ, McAdams LA, Jeste DV. Neuroleptic withdrawal in schizophrenic patients. Arch Gen Psychiatry. 1995;52:173\u201388.","journal-title":"Arch Gen Psychiatry"},{"key":"2172_CR26","doi-asserted-by":"crossref","first-page":"1835","DOI":"10.1176\/appi.ajp.158.11.1835","volume":"158","author":"M Gitlin","year":"2001","unstructured":"Gitlin M, Nuechterlein K, Subotnik KL, Ventura J, Mintz J, Fogelson DL, et al. Clinical outcome following neuroleptic discontinuation in patients with remitted recent-onset schizophrenia. Am J Psychiatry. 2001;158:1835\u201342.","journal-title":"Am J Psychiatry"},{"key":"2172_CR27","doi-asserted-by":"crossref","first-page":"e7586","DOI":"10.1136\/bmj.e7586","volume":"346","author":"A-W Chan","year":"2013","unstructured":"Chan A-W, Tetzlaff JM, G\u00f8tzsche PC, Altman DG, Mann H, Berlin JA, et al. SPIRIT 2013 explanation and elaboration: guidance for protocols of clinical trials. BMJ. 2013;346:e7586.","journal-title":"BMJ"},{"key":"2172_CR28","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1111\/eip.12108","volume":"9","author":"M Nordentoft","year":"2015","unstructured":"Nordentoft M, Melau M, Iversen T, Petersen L, Jeppesen P, Thorup A, et al. From research to practice: how OPUS treatment was accepted and implemented throughout Denmark. Early Interv Psychiatry. 2015;9:156\u201362.","journal-title":"Early Interv Psychiatry"},{"key":"2172_CR29","doi-asserted-by":"crossref","first-page":"i6681","DOI":"10.1136\/bmj.i6681","volume":"356","author":"N Albert","year":"2017","unstructured":"Albert N, Melau M, Jensen H, Emborg C, Jepsen JRM, Fagerlund B, et al. Five years of specialised early intervention versus two years of specialised early intervention followed by three years of standard treatment for patients with a first episode psychosis: randomised, superiority, parallel group trial in Denmark (OPUS II). BMJ. 2017;356:i6681.","journal-title":"BMJ"},{"key":"2172_CR30","doi-asserted-by":"crossref","DOI":"10.1017\/CBO9780511666445","volume-title":"WHO diagnosis and clinical measurement in psychiatry. A reference manual for SCAN","author":"JK Wing","year":"1998","unstructured":"Wing JK, Sartorius N, \u00dcstun TB. WHO diagnosis and clinical measurement in psychiatry. A reference manual for SCAN. Cambridge: Cambridge University Press; 1998."},{"key":"2172_CR31","volume-title":"The Scale for the Assessment of Positive Symptoms (SAPS)","author":"NC Andreasen","year":"1984","unstructured":"Andreasen NC. The Scale for the Assessment of Positive Symptoms (SAPS). Iowa City: The University of Iowa; 1984."},{"key":"2172_CR32","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1093\/schbul\/sbu001","volume":"40","author":"S Leucht","year":"2014","unstructured":"Leucht S, Samara M, Heres S, Patel MX, Woods SW, Davis JM. Dose equivalents for second-generation antipsychotics: the minimum effective dose method. Schizophr Bull. 2014;40:314\u201326.","journal-title":"Schizophr Bull"},{"key":"2172_CR33","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1001\/archpsyc.1990.01810190015002","volume":"47","author":"NC Andreasen","year":"1990","unstructured":"Andreasen NC, Flaum M, Swayze 2nd V, Tyrrell G, Arndt S. Positive and negative symptoms in schizophrenia: a critical reappraisal. Arch Gen Psychiatry. 1990;47:615\u201321.","journal-title":"Arch Gen Psychiatry"},{"key":"2172_CR34","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1097\/00004356-198809000-00001","volume":"11","author":"D Wiersma","year":"1988","unstructured":"Wiersma D, DeJong A, Ormel J. The Groningen Social Disabilities Schedule. Int J Rehabil Res. 1988;11:213\u201324.","journal-title":"Int J Rehabil Res"},{"key":"2172_CR35","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1016\/j.schres.2003.09.011","volume":"68","author":"RSE Keefe","year":"2004","unstructured":"Keefe RSE, Goldberg TE, Harvey PD, Gold JM, Poe MP, Coughenour L. The Brief Assessment of Cognition in Schizophrenia: reliability, sensitivity, and comparison with a standard neurocognitive battery. Schizophr Res. 2004;68:283\u201397.","journal-title":"Schizophr Res"},{"key":"2172_CR36","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1016\/0149-7189(82)90074-X","volume":"5","author":"CC Attkisson","year":"1982","unstructured":"Attkisson CC, Zwick R. The Client Satisfaction Questionnaire. Eval Program Plann. 1982;5:233\u20137.","journal-title":"Eval Program Plann"},{"key":"2172_CR37","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1016\/j.psychres.2007.11.012","volume":"161","author":"H Nasrallah","year":"2008","unstructured":"Nasrallah H, Morosini P, Gagnon DD. Reliability, validity and ability to detect change of the Personal and Social Performance Scale in patients with stable schizophrenia. Psychiatry Res. 2008;161:213\u201324.","journal-title":"Psychiatry Res"},{"key":"2172_CR38","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1016\/j.comppsych.2006.03.008","volume":"48","author":"G Pedersen","year":"2007","unstructured":"Pedersen G, Hagtvet KA, Karterud S. Generalizability studies of the Global Assessment of Functioning-Split version. Compr Psychiatry. 2007;48:88\u201394.","journal-title":"Compr Psychiatry"},{"key":"2172_CR39","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1093\/schbul\/sbn143","volume":"35","author":"L Wunderink","year":"2009","unstructured":"Wunderink L, Sytema S, Nienhuis FJ, Wiersma D. Clinical recovery in first-episode psychosis. Schizophr Bull. 2009;35:362\u20139.","journal-title":"Schizophr Bull"},{"key":"2172_CR40","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1016\/0306-4603(86)90040-7","volume":"11","author":"MB Sobell","year":"1986","unstructured":"Sobell MB, Sobell LC, Klajner F, Pavan D, Basian E. The reliability of a timeline method for assessing normal drinker college students\u2019 recent drinking history: utility for alcohol research. Addict Behav. 1986;11:149\u201361.","journal-title":"Addict Behav"},{"key":"2172_CR41","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1080\/00926230500232909","volume":"32","author":"A Keller","year":"2006","unstructured":"Keller A, McGarvey EL, Clayton AH. Reliability and construct validity of the Changes in Sexual Functioning Questionnaire short-form (CSFQ-14). J Sex Marital Ther. 2006;32:43\u201352.","journal-title":"J Sex Marital Ther"},{"key":"2172_CR42","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1159\/000376585","volume":"84","author":"CW Topp","year":"2015","unstructured":"Topp CW, \u00d8stergaard SD, S\u00f8ndergaard S, Bech P. The WHO-5 Well-being Index: a systematic review of the literature. Psychother Psychosom. 2015;84:167\u201376.","journal-title":"Psychother Psychosom"},{"key":"2172_CR43","unstructured":"Schwarzer R, Jerusalem M. The General Self-Efficacy Scale (GSE) [Internet]. Available from: http:\/\/www.midss.org\/content\/general-self-efficacy-scale-gse .\u00a0Accessed 25 Sept 2017."},{"key":"2172_CR44","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1007\/s00127-014-0983-0","volume":"50","author":"J Williams","year":"2015","unstructured":"Williams J, Leamy M, Bird V, Le Boutillier C, Norton S, Pesola F, et al. Development and evaluation of the INSPIRE measure of staff support for personal recovery. Soc Psychiatry Psychiatr Epidemiol. 2015;50:777\u201386.","journal-title":"Soc Psychiatry Psychiatr Epidemiol"},{"key":"2172_CR45","unstructured":"Hastrup LH, Nordentoft M, Hjorth\u00f8j C, Gyrd-Hansen D. Does the EQ-5D measure quality of life in schizophrenia? J Ment Health Policy Econ. Psychiatric Research Unit, Region Zealand, Roskilde, Denmark. lhhs@regionsjaelland.dk; 2011;14:187\u201396."},{"key":"2172_CR46","doi-asserted-by":"crossref","unstructured":"Brooks R. EuroQol: the current state of play. Health Policy (New. York). [Internet]. 1996;37:53\u201372. Available from: http:\/\/www.sciencedirect.com\/science\/article\/pii\/0168851096008226 .","DOI":"10.1016\/0168-8510(96)00822-6"},{"key":"2172_CR47","doi-asserted-by":"crossref","first-page":"602","DOI":"10.1136\/bmj.38565.415000.E01","volume":"331","author":"L Petersen","year":"2005","unstructured":"Petersen L, Jeppesen P, Thorup A, Abel M-B, \u00d8hlenschlaeger J, Christensen T\u00d8, et al. A randomised multicentre trial of integrated versus standard treatment for patients with a first episode of psychotic illness. BMJ Br Med J. 2005;331:602.","journal-title":"BMJ Br Med J"},{"key":"2172_CR48","unstructured":"Odense Patient Data Explorative Network. OPEN Randomize [Internet]. Available from: http:\/\/www.sdu.dk\/en\/om_sdu\/institutter_centre\/klinisk_institut\/forskning\/forskningsenheder\/open\/opens_faciliteter\/open+randomise . Accessed 25 Sept 2017."},{"key":"2172_CR49","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1016\/j.jbi.2008.08.010","volume":"42","author":"PA Harris","year":"2009","unstructured":"Harris PA, Taylor R, Thielke R, Payne J, Gonzalez N, Conde JG. Research electronic data capture (REDCap)\u2014A metadata-driven methodology and workflow process for providing translational research informatics support. J Biomed Inform. 2009;42:377\u201381.","journal-title":"J Biomed Inform"},{"key":"2172_CR50","unstructured":"International Committee of Medical Journal Editors. Recommendations for the conduct, reporting, editing, and publication of scholarly work in medical journals [Internet]. Available from: http:\/\/www.icmje.org .\u00a0Accessed 25 Sept 2017."},{"key":"2172_CR51","unstructured":"Ministry of Higher Education and Science. The Danish Code of Conduct for Research Integrity [Internet]. 2014. Available from: http:\/\/ufm.dk\/publikationer\/2014\/filer-2014\/the-danish-code-of-conduct-for-research-integrity.pdf .\u00a0Accessed 25 Sept 2017."},{"key":"2172_CR52","doi-asserted-by":"crossref","first-page":"508","DOI":"10.1038\/nj7152-508b","volume":"448","author":"C Beveridge","year":"2007","unstructured":"Beveridge C, Morris S. Order of merit. Nature. 2007;448:508.","journal-title":"Nature"}],"container-title":["Trials"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s13063-017-2172-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,8,3]],"date-time":"2022-08-03T19:34:28Z","timestamp":1659555268000},"score":1,"resource":{"primary":{"URL":"http:\/\/trialsjournal.biomedcentral.com\/articles\/10.1186\/s13063-017-2172-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,9,29]]},"references-count":52,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2017,12]]}},"alternative-id":["2172"],"URL":"https:\/\/doi.org\/10.1186\/s13063-017-2172-4","relation":{},"ISSN":["1745-6215"],"issn-type":[{"value":"1745-6215","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,9,29]]},"article-number":"445"}}